| S1336 |
Fluvoxamine (DU-23000) maleate
|
Fluvoxamine maleate (DU-23000, MK-264) is a selective serotonin (5-HT) reuptake inhibitor (SSRI), used in the treatment of obsessive-compulsive disorder.
|
-
Cancer Res Commun, 2025, 10.1158/2767-9764.CRC-24-0433
-
Cell Rep, 2024, 43(10):114818
-
Brain Res, 2024, 1838:149011
|
|
| S4064 |
Escitalopram Oxalate
|
Escitalopram Oxalate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) with Ki of 0.89 nM.
|
-
eLife, February 9, 2026, RP103016
-
Molecular Cancer Therapeutics, December 2, 2022, 1810-1822
-
eLife, 2026, e103016
|
|
| S3005 |
Paroxetine HCl
|
Paroxetine HCl (BRL-29060A, FG-7051) is an antidepressant drug of the SSRI type.
|
-
Molecular Therapy Oncology, December 09 2025, 201109
-
American Journal of Cancer Research, April 15 2022, 1465-1483
-
Adv Sci (Weinh), 2025, 12(33):e01981
|
|
| S5947 |
Amitriptyline
|
Amitriptyline (MK-230, N-750, Ro41575) is a tricyclic antidepressant (TCA) with analgesic properties, widely used to treat depression and neuropathic pain. This compound is an inhibitor of both serotonin transporter (SERT) and norepinephrine transporter (NET) with Ki of 3.45 nM and 13.3 nM, respectively. It also inhibits histamine receptor H1, histamine receptor H4, 5-HT2 and sigma 1 receptor with Ki of 0.5 nM, 7.31 nM, 235 nM and 287 nM, respectively. This product is a waxy solid.
|
-
Cancer Cell, 2025, 43(4):776-796.e14
-
Cancer Cell, 2025, 776-796.e14
-
Proceedings of the National Academy of Sciences, 2021, e2026403118
|
|
| S4053 |
Sertraline HCl
|
Sertraline HCl (CP-51974-1) is a 5-HT antagonist with Ki of 13 nM.
|
-
EMBO Mol Med, 2025, 17(4):625-644
-
Cell Rep, 2024, 43(10):114818
-
Antimicrob Agents Chemother, 2021, AAC.01146-20
|
|
| S2084 |
Duloxetine HCl
|
Duloxetine HCl (LY-248686) is a serotonin-norepinephrine reuptake inhibitor with Ki of 4.6 nM, used for treatment of major depressive disorder and generalized anxiety disorder (GAD).
|
-
Cancers (Basel), 2022, 14(19)4883
-
Drug Metab Dispos, 2015, 44(3):378-88
-
J Pharmacol Exp Ther, 2014, 349(3):402-7
|
|
| S1441 |
Venlafaxine HCl
|
Venlafaxine HCl(Wy 453 HCl) is an arylalkanolamine serotonin-norepinephrine reuptake inhibitor (SNRI), used to treat major depressive disorder (MDD), generalised anxiety disorder (GAD), panic disorder and social phobia.
|
-
Am J Cancer Res, 2024, 14(3):1087-1100
-
bioRxiv, 2023, 2023.07.12.548707
-
Nat Commun, 2020, 14;11(1):1825
|
|
| S2541 |
Clomipramine HCl
|
Clomipramine HCl is a tricyclic antidepressant acting as a potent inhibitor of 5-HT reuptake with an IC50 value of 1.5 nM. Clomipramine hydrochloride is used in research on depression, anxiety, and obsessive-compulsive disorder (OCD).
|
-
Infectious Medicine, 2024, 100130
-
Biomed Pharmacother, 2022, 153:113328
-
Pharmaceuticals, 2022, 241
|
|
| S3183 |
Amitriptyline HCl
|
Amitriptyline HCl is an inhibitor of both serotonin transporter (SERT) and norepinephrine transporter (NET) with Ki of 3.45 nM and 13.3 nM, respectively. This compound also inhibits histamine receptor H1, histamine receptor H4, 5-HT2 and sigma 1 receptor with Ki of 0.5 nM, 7.31 nM, 235 nM and 287 nM, respectively. It is a tricyclic antidepressant (TCA).
|
-
Proceedings of the National Academy of Sciences, 2021, e2026403118
-
Environ Toxicol Chem, 2021, 10.1002/etc.5018
-
PLoS Pathog, 2020, 16;16(3):e1008341
|
|
| S4113 |
Desvenlafaxine
|
Desvenlafaxine (WY 45233 Succinate) is a serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor with Ki of 40.2 nM and 558.4 nM, respectively.
|
-
Am J Cancer Res, 2024, 14(3):1087-1100
-
American Journal of Cancer Research, 2024, 1087-1100
-
Drug Metab Dispos, 2020, 48(10):1044-1052
|
|